Researchers investigated the use of flavoprotein fluorescence imaging as a noninvasive biomarker for metabolic stress in ...
Optos and Zeiss explain how technology is supporting early detection in practice, and one Leicestershire optometrist shares ...
OCT scans enable clinicians to identify and manage ocular pathology early – helping to prevent avoidable sight loss. While optometrists are responsible for reviewing and interpreting OCT scans, the ...
A man in his late 60s with a history of arterial hypertension, dyslipidaemia and a cerebrovascular accident 20 years ago presented to the emergency department with sudden-onset blurred vision in his ...
A tiny wireless implant is giving new hope to people blinded by advanced age-related macular degeneration. In a major international clinical trial, more than 80% of participants regained meaningful ...
Optical coherence tomography (OCT) has revolutionised the diagnosis and management of a broad spectrum of retinal disorders through its non-invasive, high-resolution cross-sectional imaging. By ...
Swept-source optical coherence tomography (SS-OCT) is an OCT variant with longer wavelengths than other commonly used OCT devices. Our aim was to determine the benefit of pre-operative SS-OCT to ...
Images showed that Parkinson’s disease is associated with a thicker photoreceptor nuclear layer and a thinner layer of photoreceptor processes. An Australian study 1 reported that directional optical ...
LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously ...
Directional OCT mitigates protocol-related variability by resolving the HFL–ONL interface, enabling separate quantification of true ONL and HFL rather than the conventional combined “presumed ONL.” ...
The retina is a specialized patch of central nervous system tissue located at the back of the eye. When the principal source of oxygen and metabolic substrates to the retina — the central retinal ...
We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving adults with acute, nonarteritic central retinal artery occlusion who had symptom onset within 4.5 hours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results